Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.
3.

Visna virus Tat protein: a potent transcription factor with both activator and suppressor domains.

Carruth LM, Hardwick JM, Morse BA, Clements JE.

J Virol. 1994 Oct;68(10):6137-46.

4.
5.
6.

Artificial zinc finger fusions targeting Sp1-binding sites and the trans-activator-responsive element potently repress transcription and replication of HIV-1.

Kim YS, Kim JM, Jung DL, Kang JE, Lee S, Kim JS, Seol W, Shin HC, Kwon HS, Van Lint C, Hernandez N, Hur MW.

J Biol Chem. 2005 Jun 3;280(22):21545-52. Epub 2005 Mar 2.

7.
8.

Identification of a cellular protein that specifically interacts with the essential cysteine region of the HIV-1 Tat transactivator.

Kamine J, Elangovan B, Subramanian T, Coleman D, Chinnadurai G.

Virology. 1996 Feb 15;216(2):357-66.

9.
10.

Activation of the JC virus Tat-responsive transcriptional control element by association of the Tat protein of human immunodeficiency virus 1 with cellular protein Pur alpha.

Krachmarov CP, Chepenik LG, Barr-Vagell S, Khalili K, Johnson EM.

Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14112-7. Erratum in: Proc Natl Acad Sci U S A 1997 Aug 19;94(17):9571.

11.

HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors.

Ambrosino C, Ruocco MR, Chen X, Mallardo M, Baudi F, Trematerra S, Quinto I, Venuta S, Scala G.

J Biol Chem. 1997 Jun 6;272(23):14883-92.

13.
14.

Developmental regulators containing the I-mfa domain interact with T cyclins and Tat and modulate transcription.

Wang Q, Young TM, Mathews MB, Pe'ery T.

J Mol Biol. 2007 Mar 30;367(3):630-46. Epub 2007 Jan 12.

18.

Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanism.

Bieniasz PD, Grdina TA, Bogerd HP, Cullen BR.

Mol Cell Biol. 1999 Jul;19(7):4592-9.

20.

Human immunodeficiency virus type 1 and 2 Tat proteins specifically interact with RNA polymerase II.

Mavankal G, Ignatius Ou SH, Oliver H, Sigman D, Gaynor RB.

Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2089-94.

Supplemental Content

Support Center